Form 4: Director Joseph Pellegrino JR Acquires LMAT Shares & Options

LEMAITRE VASCULAR Director Joseph P. Pellegrino JR acquired 533 shares of common stock and 3,431 stock options on December 10, 2025, as part of equity awards.

Summary

• Joseph P. Pellegrino JR, a Director at LEMAITRE VASCULAR INC (LMAT), reported changes in his beneficial ownership.
• On December 10, 2025, Mr. Pellegrino acquired 533 shares of common stock through a restricted stock unit (RSU) award.
• These RSUs vest on a time-based schedule: 33 1/3% on December 1, 2026, with the remainder vesting in equal annual installments over the subsequent two years.
• Following this transaction, Mr. Pellegrino directly beneficially owns 10,122 shares of common stock.
• Additionally, on December 10, 2025, Mr. Pellegrino acquired 3,431 stock options with an exercise price of $83.66.
• These stock options vest over a three-year period, with 33 1/3% vesting on the first anniversary of December 1, 2025, and the balance vesting in equal annual installments over the remaining two years.
• The stock options have an expiration date of December 10, 2030.
• Following this transaction, Mr. Pellegrino directly beneficially owns 3,431 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The acquisition of shares and options by a director is generally positive as it increases insider ownership and aligns interests with shareholders, reflecting confidence in the company's future. This is a routine compensation event.

Positives

• The acquisition of common stock and stock options by a director increases insider ownership, aligning management's interests with those of shareholders.
• Equity awards are a common form of compensation, indicating continued commitment and incentivization of key personnel.

Future Outlook

The filing details future vesting schedules for the restricted stock units and stock options, indicating a long-term incentive structure for the director.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity compensation, common across all publicly traded companies as a mechanism to align executive and director interests with shareholder value.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholder value through equity ownership.
• Employees: Standard equity compensation practices can positively influence employee morale and retention by demonstrating a commitment to performance-based incentives.

Next Steps

• The restricted stock units will vest 33 1/3% on December 1, 2026, with the balance vesting in equal annual installments over the subsequent two years.
• The stock options will vest 33 1/3% on the first anniversary of December 1, 2025, with the balance vesting in equal annual installments over the remaining two years.

Key Dates

Recommendation

This Form 4 reports a routine equity award to a director, which is a common compensation practice. While it indicates continued alignment of interests, it does not present new fundamental information or a significant shift in company outlook that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as it reflects no immediate catalyst for a buy or sell decision based solely on this filing.

Keywords

LEMAITRE VASCULAR, LMAT, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, Equity Award, Director, Beneficial Ownership